136 related articles for article (PubMed ID: 2529420)
1. [Contact allergies caused by bufexamac].
Geier J; Fuchs T
Med Klin (Munich); 1989 Jul; 84(7):333-8. PubMed ID: 2529420
[TBL] [Abstract][Full Text] [Related]
2. [Contact allergy to bufexamac].
Frosch PJ; Raulin C
Hautarzt; 1987 Jun; 38(6):331-4. PubMed ID: 2958428
[TBL] [Abstract][Full Text] [Related]
3. [A common and insidious side-effect: allergic contact dermatitis caused by bufexamac used in the treatment of dermatitis. Results from the Information Network of Departments of Dermatology (IDVK)].
Schnuch A; Gefeller O; Uter W
Dtsch Med Wochenschr; 2005 Dec; 130(50):2881-6. PubMed ID: 16342011
[TBL] [Abstract][Full Text] [Related]
4. Allergic contact dermatitis to topical preparations of bufexamac.
Pan Y; Nixon R
Australas J Dermatol; 2012 Aug; 53(3):207-10. PubMed ID: 22881467
[TBL] [Abstract][Full Text] [Related]
5. [Severe contact dermatitis caused by Parfenac cream].
Collet E; Lacroix M; Boulitrop Morvan C; Dalac S; Sallin J; Lambert D
Ann Dermatol Venereol; 1993; 120(12):892-3. PubMed ID: 8074349
[TBL] [Abstract][Full Text] [Related]
6. [Severe allergic contact dermatitis with generalized spread due to bufexamac presenting as the "baboon" syndrome].
Proske S; Uter W; Schnuch A; Hartschuh W
Dtsch Med Wochenschr; 2003 Mar; 128(11):545-7. PubMed ID: 12635026
[TBL] [Abstract][Full Text] [Related]
7. [A severe epicutaneous test reaction to the bufexamac in a hemorrhoidal therapeutic preparation].
Bauer A; Greif C; Gebhardt M; Elsner P
Dtsch Med Wochenschr; 1999 Oct; 124(40):1168-70. PubMed ID: 10548947
[TBL] [Abstract][Full Text] [Related]
8. Contact sensitivity to bufexamac.
Lachapelle JM
Contact Dermatitis; 1975 Aug; 1(4):261. PubMed ID: 139242
[No Abstract] [Full Text] [Related]
9. Severe cutaneous eruptions following the topical use of preparations containing bufexamac: Is it time to reconsider its registration in Australia?
Harris AG; Saikal SL; Scurry J; Relic J; Nixon RL; Chee P
Australas J Dermatol; 2019 Feb; 60(1):53-56. PubMed ID: 30155971
[TBL] [Abstract][Full Text] [Related]
10. Allergic contact dermatitis from bufexamac cream.
Corazza M; Roveggio C; Virgili A
Contact Dermatitis; 1993 Oct; 29(4):219. PubMed ID: 8281796
[No Abstract] [Full Text] [Related]
11. Acute generalized exanthematous pustulosis induced by bufexamac in an atopic girl.
Belhadjali H; Ghannouchi N; Njim L; Mohamed M; Moussa A; Bayou F; Chakroun M; Zakhama A; Zili J
Contact Dermatitis; 2008 Apr; 58(4):247-8. PubMed ID: 18353041
[No Abstract] [Full Text] [Related]
12. Contact dermatitis due to bufexamac.
Melino M; Bardazzi F; Manuzzi P
Contact Dermatitis; 1987 May; 16(5):287. PubMed ID: 2957160
[No Abstract] [Full Text] [Related]
13. Erythema-multiforme-like, urticarial papular and plaque eruptions from bufexamac: report of 4 cases.
Koch P; Bahmer FA
Contact Dermatitis; 1994 Aug; 31(2):97-101. PubMed ID: 7750277
[TBL] [Abstract][Full Text] [Related]
14. Contact dermatitis to bufexamac.
Reiffers J
Dermatologica; 1982 May; 164(5):354-6. PubMed ID: 7095225
[No Abstract] [Full Text] [Related]
15. Epidemiological significance of bufexamac as a frequent and relevant contact sensitizer.
Kränke B; Szolar-Platzer C; Komericki P; Derhaschnig J; Aberer W
Contact Dermatitis; 1997 Apr; 36(4):212-5. PubMed ID: 9165205
[TBL] [Abstract][Full Text] [Related]
16. General dermatologic use of hydroxamic acid.
Solano E
Clin Ther; 1980; 3(4):229-33. PubMed ID: 7273060
[TBL] [Abstract][Full Text] [Related]
17. [Anogenital dermatoses--allergic and irritative causative factors. Analysis of IVDK data and review of the literature].
Kügler K; Brinkmeier T; Frosch PJ; Uter W
J Dtsch Dermatol Ges; 2005 Dec; 3(12):979-86. PubMed ID: 16405714
[TBL] [Abstract][Full Text] [Related]
18. [Contact allergy caused by triethanolamine].
Scheuer B
Hautarzt; 1983 Mar; 34(3):126-9. PubMed ID: 6222016
[TBL] [Abstract][Full Text] [Related]
19. [Comparative testing of Kamillosan cream and steroidal (0.25% hydrocortisone, 0.75% fluocortin butyl ester) and non-steroidal (5% bufexamac) dermatologic agents in maintenance therapy of eczematous diseases].
Aertgeerts P; Albring M; Klaschka F; Nasemann T; Patzelt-Wenczler R; Rauhut K; Weigl B
Z Hautkr; 1985 Feb; 60(3):270-7. PubMed ID: 3158124
[TBL] [Abstract][Full Text] [Related]
20. [Post-therapeutic benzoyl peroxide contact allergy in ulcus cruris patients].
Bandmann HJ; Agathos M
Hautarzt; 1985 Dec; 36(12):670-4. PubMed ID: 2935511
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
